Global Amyotrophic Lateral Sclerosis Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 933809 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Riluzole
        1.2.3 Edaravone (Radicava)
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Drugs Store
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Perspective (2016-2027)
    2.2 Amyotrophic Lateral Sclerosis Therapeutics Growth Trends by Regions
        2.2.1 Amyotrophic Lateral Sclerosis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Amyotrophic Lateral Sclerosis Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Amyotrophic Lateral Sclerosis Therapeutics Industry Dynamic
        2.3.1 Amyotrophic Lateral Sclerosis Therapeutics Market Trends
        2.3.2 Amyotrophic Lateral Sclerosis Therapeutics Market Drivers
        2.3.3 Amyotrophic Lateral Sclerosis Therapeutics Market Challenges
        2.3.4 Amyotrophic Lateral Sclerosis Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Revenue
        3.1.1 Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis Therapeutics Revenue
    3.4 Global Amyotrophic Lateral Sclerosis Therapeutics Market Concentration Ratio
        3.4.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Therapeutics Revenue in 2020
    3.5 Amyotrophic Lateral Sclerosis Therapeutics Key Players Head office and Area Served
    3.6 Key Players Amyotrophic Lateral Sclerosis Therapeutics Product Solution and Service
    3.7 Date of Enter into Amyotrophic Lateral Sclerosis Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Amyotrophic Lateral Sclerosis Therapeutics Breakdown Data by Type
    4.1 Global Amyotrophic Lateral Sclerosis Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Amyotrophic Lateral Sclerosis Therapeutics Breakdown Data by Application
    5.1 Global Amyotrophic Lateral Sclerosis Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size (2016-2027)
    6.2 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type
        6.2.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2027)
    6.3 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application
        6.3.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2027)
    6.4 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country
        6.4.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size (2016-2027)
    7.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type
        7.2.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application
        7.3.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country
        7.4.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size (2016-2027)
    9.2 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type
        9.2.1 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application
        9.3.1 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country
        9.4.1 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Mitsubishi Tanabe Pharma
        11.1.1 Mitsubishi Tanabe Pharma Company Details
        11.1.2 Mitsubishi Tanabe Pharma Business Overview
        11.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
        11.1.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
        11.1.5 Mitsubishi Tanabe Pharma Recent Development
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Introduction
        11.2.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
        11.2.5 Sanofi Recent Development
    11.3 Mylan Pharma
        11.3.1 Mylan Pharma Company Details
        11.3.2 Mylan Pharma Business Overview
        11.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
        11.3.4 Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
        11.3.5 Mylan Pharma Recent Development
    11.4 Apotex
        11.4.1 Apotex Company Details
        11.4.2 Apotex Business Overview
        11.4.3 Apotex Amyotrophic Lateral Sclerosis Therapeutics Introduction
        11.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
        11.4.5 Apotex Recent Development
    11.5 Glemark Generics
        11.5.1 Glemark Generics Company Details
        11.5.2 Glemark Generics Business Overview
        11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Introduction
        11.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
        11.5.5 Glemark Generics Recent Development
    11.6 Covis Pharma
        11.6.1 Covis Pharma Company Details
        11.6.2 Covis Pharma Business Overview
        11.6.3 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
        11.6.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
        11.6.5 Covis Pharma Recent Development
    11.7 Sun Pharma
        11.7.1 Sun Pharma Company Details
        11.7.2 Sun Pharma Business Overview
        11.7.3 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
        11.7.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
        11.7.5 Sun Pharma Recent Development
    11.8 Lunan Pharma
        11.8.1 Lunan Pharma Company Details
        11.8.2 Lunan Pharma Business Overview
        11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
        11.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
        11.8.5 Lunan Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Riluzole
    Table 3. Key Players of Edaravone (Radicava)
    Table 4. Key Players of Other
    Table 5. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Regions (2016-2021)
    Table 9. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Regions (2022-2027)
    Table 11. Amyotrophic Lateral Sclerosis Therapeutics Market Trends
    Table 12. Amyotrophic Lateral Sclerosis Therapeutics Market Drivers
    Table 13. Amyotrophic Lateral Sclerosis Therapeutics Market Challenges
    Table 14. Amyotrophic Lateral Sclerosis Therapeutics Market Restraints
    Table 15. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Players (2016-2021)
    Table 17. Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Therapeutics as of 2020)
    Table 18. Ranking of Global Top Amyotrophic Lateral Sclerosis Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Amyotrophic Lateral Sclerosis Therapeutics Product Solution and Service
    Table 22. Date of Enter into Amyotrophic Lateral Sclerosis Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Type (2016-2021)
    Table 26. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Application (2016-2021)
    Table 30. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Mitsubishi Tanabe Pharma Company Details
    Table 63. Mitsubishi Tanabe Pharma Business Overview
    Table 64. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
    Table 65. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 66. Mitsubishi Tanabe Pharma Recent Development
    Table 67. Sanofi Company Details
    Table 68. Sanofi Business Overview
    Table 69. Sanofi Amyotrophic Lateral Sclerosis Therapeutics Product
    Table 70. Sanofi Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 71. Sanofi Recent Development
    Table 72. Mylan Pharma Company Details
    Table 73. Mylan Pharma Business Overview
    Table 74. Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
    Table 75. Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 76. Mylan Pharma Recent Development
    Table 77. Apotex Company Details
    Table 78. Apotex Business Overview
    Table 79. Apotex Amyotrophic Lateral Sclerosis Therapeutics Product
    Table 80. Apotex Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 81. Apotex Recent Development
    Table 82. Glemark Generics Company Details
    Table 83. Glemark Generics Business Overview
    Table 84. Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Product
    Table 85. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 86. Glemark Generics Recent Development
    Table 87. Covis Pharma Company Details
    Table 88. Covis Pharma Business Overview
    Table 89. Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
    Table 90. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 91. Covis Pharma Recent Development
    Table 92. Sun Pharma Company Details
    Table 93. Sun Pharma Business Overview
    Table 94. Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
    Table 95. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 96. Sun Pharma Recent Development
    Table 97. Lunan Pharma Company Details
    Table 98. Lunan Pharma Business Overview
    Table 99. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. Lunan Pharma Recent Development
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Riluzole Features
    Figure 3. Edaravone (Radicava) Features
    Figure 4. Other Features
    Figure 5. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application: 2020 VS 2027
    Figure 6. Hospital Case Studies
    Figure 7. Drugs Store Case Studies
    Figure 8. Other Case Studies
    Figure 9. Amyotrophic Lateral Sclerosis Therapeutics Report Years Considered
    Figure 10. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 13. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Regions (2022-2027)
    Figure 14. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Players in 2020
    Figure 15. Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Therapeutics as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Therapeutics Revenue in 2020
    Figure 17. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 18. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 19. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2016-2027)
    Figure 21. North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2016-2027)
    Figure 22. North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2016-2027)
    Figure 23. United States Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2016-2027)
    Figure 27. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2016-2027)
    Figure 28. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2016-2027)
    Figure 29. Germany Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region (2016-2027)
    Figure 39. China Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2016-2027)
    Figure 47. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2016-2027)
    Figure 48. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2016-2027)
    Figure 49. Mexico Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2016-2027)
    Figure 55. Turkey Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
    Figure 59. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
    Figure 60. Mylan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
    Figure 61. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
    Figure 62. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
    Figure 63. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
    Figure 64. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
    Figure 65. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2016-2021)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
Frequently Asked Questions
Amyotrophic Lateral Sclerosis Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Amyotrophic Lateral Sclerosis Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Amyotrophic Lateral Sclerosis Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports